comparemela.com

Latest Breaking News On - Amy jobe - Page 1 : comparemela.com

New village shop breathes life into South Elkington community

Celebrating local produce

South elkingtonUnited kingdomAmy jobeJohn aron

Aligos Therapeutics to Present at the Jefferies 2023 Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 24, 2023 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver. | June 11, 2023

Amy jobeLawrencem blattCorey davisLawrence blattLifesci communicationsAligos therapeutics incJefferies healthcare conferenceHealthcare conference information

Stock Market | FinancialContent Business Page

FinancialContent fully hosted finance channel

Lawrence blattCorey davisLawrencem blattAmy jobeAligos therapeutics incLifesci communicationsJefferies healthcare conferenceHealthcare conference information

Aligos Therapeutics Announces Research Collaboration and Development Agreement with Xiamen Amoytop Biotech Co Ltd for Use of Aligos Oligonucleotide Platform for the Treatment of Liver Diseases

SOUTH SAN FRANCISCO, Calif., May 12, 2023 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver. | May 12, 2023

Sun liCorey davisAmy jobeLawrence blattXiamen amoytop biotech coAligos therapeutics incLifesci communicationsExchange commissionExchange commission onXiamen amoytop biotechGreater chinaSecurities litigation reform actAligo quarterly reportAligos therapeuticsNc stock exchangePress release

Aligos Therapeutics to Present Data from Chronic Hepatitis

SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company.

Jin hongLawrence blattAlina jucovCorey davisKusum guptaJinlin houYannick debingAmy jobeTongfei wuExchange commissionExchange commission onAligos therapeutics incLifesci communicationsEuropean associationScientific presentationsSecurities litigation reform act

vimarsana © 2020. All Rights Reserved.